A1ln34 Stock Short Ratio
| A1LN34 Stock | BRL 73.85 0.35 0.48% |
A1LN34 fundamentals help investors to digest information that contributes to A1LN34's financial success or failures. It also enables traders to predict the movement of A1LN34 Stock. The fundamental analysis module provides a way to measure A1LN34's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to A1LN34 stock.
A1LN34 |
A1LN34 Company Short Ratio Analysis
A1LN34's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Based on the latest financial disclosure, A1LN34 has a Short Ratio of 0.0 times. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The short ratio for all Brazil stocks is 100.0% higher than that of the company.
Did you try this?
Run USA ETFs Now
USA ETFsFind actively traded Exchange Traded Funds (ETF) in USA |
| All Next | Launch Module |
A1LN34 Fundamentals
| Return On Equity | -78.71 | |||
| Return On Asset | -13.65 | |||
| Profit Margin | (128.96) % | |||
| Operating Margin | (109.35) % | |||
| Current Valuation | 5.15 B | |||
| Shares Outstanding | 2.35 B | |||
| Price To Book | 6.22 X | |||
| Price To Sales | 170.35 X | |||
| Revenue | 687.53 M | |||
| Gross Profit | 414.8 M | |||
| EBITDA | (708.47 M) | |||
| Net Income | (886.68 M) | |||
| Cash And Equivalents | 1.9 B | |||
| Cash Per Share | 15.99 X | |||
| Total Debt | 761.07 M | |||
| Debt To Equity | 0.89 % | |||
| Current Ratio | 4.91 X | |||
| Book Value Per Share | 7.89 X | |||
| Cash Flow From Operations | (590.99 M) | |||
| Earnings Per Share | (37.45) X | |||
| Number Of Employees | 1.45 K | |||
| Beta | 1.2 | |||
| Market Capitalization | 117.12 B | |||
| Z Score | 91.8 |
About A1LN34 Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze A1LN34's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of A1LN34 using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of A1LN34 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in A1LN34 Stock
A1LN34 financial ratios help investors to determine whether A1LN34 Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in A1LN34 with respect to the benefits of owning A1LN34 security.